How many studies have been conducted on Xipamide?

BiohacksAI has indexed 120 PubMed studies on Xipamide, including 16 randomized controlled trials (RCTs). 43% of studies involve human subjects.

What are the main research areas for Xipamide?

The primary research domains for Xipamide are ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic. This is based on analysis of 120 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Xipamide

A sulfamoylbenzamide analog of CLOPAMIDE. It is diuretic and saluretic with antihypertensive activity. It is bound to PLASMA PROTEINS, thus has a delayed onset and prolonged action.

120+ PubMed studies analyzed · 16 RCTs · Evidence Score: 47.3

Research Domains

Xipamide has been studied across 13 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 34% of studies addressing this area.

Loading evidence profile...

This evidence profile for Xipamide is generated deterministically from 120 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.